*** For details on how to be removed from this list visit the ***
*** CCP4 home page http://www.ccp4.ac.uk ***
Hi, Juergen
Thanks for your help!
Our most interested inhibitor has a fairly good solubility, it didn't
precipitate in both 2% and 10% DMSO. However, other inhibitors precipitated
more or less after being added to the protein solution. Do you think adding the
stock solution of the inhibitors (in 100% DMSO) stepwisely and slowly into the
protein solution could help them dissolve better? Solubility is really a big
problem to us working on protein:inhibitor complexes.
Now I think not including the inhibitors in the cryo-portectant is very likely
to be the cause of inhibitors missing in my map, like you and many other CCP4bb
users, Jeffery Ohren, George Wisedchasri, Ekstrom Fredrik, Anthony Addlagatta
have all mentioned to me. Thanks for all the quick responses, they're very
helpful to me. I will add ligands in the cryo next time.
Yes, the F(complex)-F(uncomplexed) difference map is what I need. I found this
method in an old post by Zsolt Bocskei in 2001, he mentioned that Gerard
Bricogne had suggested him using F(complex)-F(uncomplexed) instead of
F(complex)-F(calculated from the model) to construct difference map for
inspecting ligands. I am a newbie in protein crystallography, and I am not
clear about the difference between them. Could any one give me some idea?
Thanks again!
Tiancen Hu
======= 2005-12-19 01:47:16 您在来信中写道:=======
>Hi Tony,
>
>> Protein : inhibitor mixture:
>>
>> [protein]: 10mg/ml, ~0.3mM
>>
>> [inhibitor]: ~2mM (with 2%DMSO in the mixture) or ~10mM (with 10%DMSO)
>>
>> The protein and inhibitors were incubated on ice for >3hr.
>>
>> The MWs of the inhibitors are all larger than 400.
>>
>You assume that you have a monomer in the asu ? If you have more than
>that you might want to take the ratio into account for your excess
>amount of inhibitor. Is your inhibitor sufficiently soluble in 2% DMSO ?
>
>> Reservoir: 0.1M Hepes pH 7.5, 0.1-0.4M Mg(Ac)_2 , 10-20% PEG4K / PEG6K
>> / PEG8K (different inhibitor:protein mixture produces crystals in
>> different combination of Mg(AC)_2 concentration and PEG)
>>
>> Cryo-protectant: 30% Glycerol added to the same mother liquor,
>> crystals soaked for 1min �C 5min before being flash cooled in liquid
>> nitrogen.
>>
>Did your Cryo contained the inhibitors in the same or even higher
>concentration as your original setup for co-crystallization ? If not you
>have reduced the [Inhibitor] bei almost 1/3.
>
>> 6 sets of data were collected, 1 from native crystal, 2 from “2mM
>> inhibitor” crystals, 3 from “10mM inhibitor” crystals (one of the
>> inhibitor “produced” crystals both at 2mM and 10mM).
>>
>> The qualities of the datasets are all good, but the result was
>> frustrating, I couldn’t find any “inhibitor-like” density map from any
>> of these datasets. So these are my questions:
>>
>> 1. What could be the possible reasons for these inhibitors missing in
>> the density map? I suspected that it could be the high DMSO
>> concentration in the mixture, or the high glycerol concentration in
>> the cryo-protectant, or that I soaked the crystals in the
>> cyro-protectant for too long, which caused the inhibitors “drop off”
>> from the protein. If so, how could I deal with them?
>>
>Increase the [Inhibitor] in the cryo.
>
>> 2. I constructed the difference map from the measured amplitudes of
>> “complex” crystals and the structure factors of a model downloaded
>> from PDB. And I happened to read from the ccp4bb archive that there is
>> also a way of calculating difference map between the measured
>> amplitudes from the “complex” and those from native crystals. But I
>> have no idea how to do this, could any one give me some advice?
>>
>I think you want to use F(complex)-F(uncomplexed) ? or 2Fc - Fu. If that
>is the case you need to scale the two differnet datasets first and then
>run fft with the correct labels.
>
>Not sure if I understood you correctly here.
>
>Juergen
>
>> Thanks in advance!
>>
>> Tiancen Hu
>>
>> Drug Discovery and Design Center
>>
>> Shanghai Institute of Materia Medica
>>
>> Room 2107, #555, ZuChongzhi Road
>>
>> Shangahi 201203, P.R. China
>>
>> Phone: 0086-(0)21-50806600 ext. 2107
>>
>> Email: [EMAIL PROTECTED]
>>
>>
>>
>>
>>
>>
>>
>>
>>
>>
>>
>>
>> 完 全 免 费 & 无 限 容 量 = 你 的 网 易 相 册
>> <http://adclient.163.com/event.ng/Type=click&FlightID=46628&AdID=48547&TargetID=635&Segments=80,94,289,416&Targets=1758,92,635&Values=31,43,51,60,72,78,82,91,100,110,150,312,330,332,457,499,586,615,702,733,734&RawValues=&Redirect=http://photo.163.com/>
>
>
>
>--
>Jürgen Bosch
>Howard Hughes Medical Institute and
>University of Washington
>Dept. of Biochemistry, K-418
>1705 NE Pacific Street
>Seattle, WA 98195
>Box 357742
>Phone: +1-206-616-4542
>FAX: +1-206-685-7002
= = = = = = = = = = = = = = = = = = = =
致
礼!
Tiancen Hu
[EMAIL PROTECTED]
2005-12-19